Hospital for Special Surgery, New York, New York.
Weill Cornell Medical College, New York, New York.
Sports Health. 2019 Sep/Oct;11(5):461-466. doi: 10.1177/1941738119861545. Epub 2019 Jul 24.
Viscosupplementation is widely used for management of knee osteoarthritis. Many formulations of hyaluronic acid (HA) are available, ranging from a single injection to a series of up to 5 injections per treatment.
To compare efficacy between single and multiple HA injection formulations.
MEDLINE, EMBASE, Cochrane, Web of Science, Scopus databases were all searched.
Full-text prospective randomized and nonrandomized controlled human trials, cohort studies, and cost-effectiveness evaluations in the English language comparing different injection regimens of viscosupplementation were included.
Systematic review.
Level 1.
Data were collected using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Four databases were searched by a librarian and the principal investigator, identifying 6196 articles for screening.
Eleven studies met the inclusion criteria. Of the studies comparing single- with multiple-injection formulations of HA for treatment of knee osteoarthritis, there was no consistent difference in patient-reported outcomes. Furthermore, 5-injection formulations do not appear to be superior to 3-injection formulations.
There are limited head-to-head trials comparing viscosupplementation formulations that differ based on number of injections, and in particular, there is a paucity of trials evaluating single-injection formulations. Based on the currently available data, there appears to be similar efficacy with the possibility for greater cost-effectiveness and less patient inconvenience with single-injection formulations.
黏弹性补充疗法被广泛用于膝关节骨关节炎的治疗。有多种透明质酸(HA)制剂可供选择,从单次注射到每次治疗最多 5 次注射的系列制剂都有。
比较单次和多次 HA 注射制剂的疗效。
检索 MEDLINE、EMBASE、Cochrane、Web of Science 和 Scopus 数据库。
纳入了全文前瞻性随机和非随机对照人体试验、队列研究和成本效益评估,这些研究比较了不同黏弹性补充疗法注射方案。
系统评价。
1 级。
使用 PRISMA(系统评价和荟萃分析的首选报告项目)指南收集数据。由图书馆员和主要研究者对 4 个数据库进行了检索,筛选出 6196 篇文章。
有 11 项研究符合纳入标准。在比较 HA 单次与多次注射制剂治疗膝关节骨关节炎的研究中,患者报告的结局没有一致的差异。此外,5 次注射制剂似乎并不优于 3 次注射制剂。
目前基于注射次数不同比较黏弹性补充疗法制剂的头对头试验有限,特别是评估单次注射制剂的试验很少。根据目前可用的数据,单次注射制剂似乎具有相似的疗效,并且具有更高的成本效益和更少的患者不便性的可能性。